Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer

Clinical trial NCT00003264 · COMPLETED

Trial details

NCT number: NCT00003264
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 1997-10-01
Primary completion: 2002-02-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.